Leadership Team

The Executive Leadership Team works alongside the Board of Directors to set and influence our strategic direction, while providing leadership both within the organisation and externally, as ambassadors and thought leaders.

Dr Richard Scott

Interim CEO

Read bio

Dr Ellen Thomas

Interim Chief Medical Officer

Read bio

Professor Matt Brown

Chief Scientific Officer

Read bio

Catherine Byers

Chief Financial and Performance Officer

Read bio

Jackie Kinsey

Chief People Officer

Read bio

Nick Maltby

General Counsel, Company Secretary and Data Protection Officer

Read bio

Parker Moss

Chief Ecosystems and Partnership Officer

Read bio

Rakhi Rajani

Chief Digital and Strategy Officer

Read bio

Dr Augusto Rendon

Chief Bioinformatician

Read bio

Pete Sinden

Chief Information Officer

Chris Schonewald

Chief of Staff and Director of Strategy

Read bio

Board

The Genomics England Board oversees all of our activities, ratifies all major decisions and sets the overall strategy for the organisation. Genomics England has several independent advisory committees that report to the board. These include the Ethics Advisory Committee, Science Advisory Committee, Data Advisory Committee, Access Review Committee, GeCIP Board and the Audit Committee.

Dr Richard Scott

Interim CEO

Read bio

Baroness Nicola Blackwood

Chair

Read bio

Dr Vikram Bajaj

Non-Executive Director

Professor Sir John Bell

Non-Executive Director, Chair of Scientific Advisory Committee

Read bio

Professor Ewan Birney

Non-Executive Director

Read bio

Professor Matt Brown

Chief Scientific Officer

Read bio

Roz Campion

Director, Office for Life Sciences

Andrew Eland

Non-Executive Director

Read bio

Dr Tim Ferris

Non-Executive Director

Read bio

Dr Annalisa Jenkins

Non-Executive Director

Read bio

Nicola Perrin MBE

Non-Executive Director

Read bio

Dr Keith Stewart

Non-Executive Director

Read bio

Sir Jonathan Symonds CBE

Non-Executive Director

Read bio

Participant Panel

The Participant Panel sits at the heart of Genomics England and is made up of participants from the 100,000 Genomes Project, and parents or carers of people involved in this project. It is expanding to include patients and relatives from the GenOMICC COVID-19 study and NHS patients who give consent for their whole genome sequences and associated health data to be used for research in the Genomics England National Genomic Research Library.

The Panel acts as an advisory body to the Genomics England Board, working to ensure that the health data held by Genomics England is being looked after with respect and used in the best interests of our participants.

Jillian Hastings Ward

Chair of the Participant Panel

Read bio

Rebecca Middleton

Vice Chair for Rare Conditions

Read bio

Helen White

Vice Chair for Cancer

Read bio

Frances Allan

Participant Panel member

Read bio

Paul Arvidson

Participant Panel member

Read bio

Lisa Beaton

Participant Panel member

Read bio

Cecily Berryman

Participant Panel member

Read bio

Dr Helen Bulbeck

Participant Panel member

Read bio

Dr Latha Chandramouli

Participant Panel member

Read bio

Mel Dixon

Participant Panel member

Read bio

Alison Fox

Participant Panel member

Read bio

Kate Grafton

Participant Panel member

Read bio

Andy Hart

Participant Panel member

Read bio

Clarissa Hopkins

Participant Panel member

Read bio

Peter Hopper

Participant Panel member

Read bio

Hannah Humphrey

Participant Panel member

Read bio

Ismael Kherroubi García

Participant Panel member

Read bio

Anthony Locke

Participant Panel member

Read bio

Dave McCormick

Participant Panel member

Read bio

Helen Mendis

Participant Panel member

Read bio

Shelley Simmonds

Participant Panel member

Read bio

Dominique Stephens

Participant Panel member

Read bio

Emma Walters

Participant Panel member

Read bio

Science Advisory Committee

Our independent Science Advisory Committee advises the Genomics England Board on scientific aspects of the company's projects. This includes overseeing: disease inclusion criteria; Genomics England Clinical Interpretation Partnership (GeCIP) domain formation; data access request applications; and patient recruitment strategies. The Committee considers the interests of patients, the public, scientists and clinicians engaged in genomic research or genomic medicine.

Professor Sir John Bell

Non-Executive Director, Chair of Scientific Advisory Committee

Read bio

Professor Tim Aitman

University of Edinburgh

Read bio

James Brenton

Cancer Research UK Cambridge Institute

Read bio

Professor Sir John Burn

Newcastle University

Read bio

Professor Patrick Chinnery

University of Cambridge

David Church

Andrew Fry

Professor Dame Sue Hill

NHS England

Read bio

Professor Matthew Hurles

Wellcome Sanger Institute

Professor Mark Lawler

HDR UK

Professor David Lomas

Deputy Chair, Scientific Advisory Committee and Interim Chair, Access Review Committee

Read bio

Professor Anna Schuh

University of Oxford

Read bio

Professor Matt Seymour

University of Leeds

Read bio

Dr Samra Turajlic

Cancer Research UK

Read bio

Professor Andrew Wilkie

University of Oxford

Read bio

Ethics Advisory Committee

Our independent Ethics Advisory Committee identifies, defines, examines and responds to ethical issues in the 100,000 Genomes Project. They also help to ensure the Project is delivered in the interests of the public and of participants.

They provide timely advice, guidance, review and recommendations on ethical issues, as requested by the Board.

Dr Latha Chandramouli

Participant Panel member

Read bio

Professor Angus Clarke

Cardiff University

Read bio

Anne Croudass

Cancer Research UK

Read bio

Alison Hall

PHG Foundation

Read bio

Ismael Kherroubi García

Participant Panel member

Read bio

Professor Anneke Lucassen

University of Southampton

Read bio

Professor Penney Lewis

King’s College London

Nicola Perrin MBE

Non-Executive Director

Read bio

Dr Nadeem Qureshi

University of Nottingham

Read bio

Dr Ron Zimmern

PHG Foundation

Read bio

Richard Stephens

Patient Representative & NCRI

Read bio

Shelley Simmonds

Participant Panel member

Read bio

Access Review Committee

The Access Review Committee’s (ARC) role is to provide an independent examination and response to requests for access to genomic and health data held in the Genomics England National Genomic Research Library. These requests come from academic researchers, clinicians, and commercial researchers.

There is a set application process for these individuals to go through to access the data. The ARC reviews these applications to check that they are in line with the aims of the National Genomic Research Library Protocol and to assess whether they are in the interest of both the public and the participants. 

Jillian Hastings Ward

Chair of the Participant Panel

Read bio

Kate Grafton

Participant Panel member

Read bio

Peter Hopper

Participant Panel member

Read bio

Professor APS Hungin

OBE MD FRCP FRCGP FRSA

Read bio

Professor David Lomas

Deputy Chair, Scientific Advisory Committee and Interim Chair, Access Review Committee

Read bio

Richard Stephens

Patient Representative & NCRI

Read bio

GECIP Board

The Genomics England Clinical Interpretation Partnership (GECIP) consists of groups or ‘domains’, overseen by the GECIP Board.

Each domain covers a different disease or topic in the project. The groups are responsible for interpreting the data to improve clinical care, and also undertake complementary research, including medical, computational and social research.

The GECIP Board oversees the operation of GECIP and includes representatives from GECIP funders and the GECIP domains. Up to three places on the GECIP Board are reserved for the representatives of the Participant Panel and they contribute and vote as any other member of the GECIP Board. The individual Participant Panel representatives are free to rotate attendance at the GECIP Board according to their availability.